From disease modification to disease control in rheumatoid arthritis.
In the development of therapies to treat rheumatoid arthritis, measurement of response is essential. Such measurement has incrementally advanced from symptom modification through radiological improvement to a requirement for change in inflammation, change in function, and the prevention of further structural damage.
Furst
D E
DE
Section of Rheumatology and Immunology, Virginia Mason Medical Center, Seattle, Washington 98111, USA.
D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000517:prevention & control*; D018563:Disease Notification; D006801:Humans; D011859:Radiography; D016896:Treatment Outcome
D018501:Antirheumatic Agents